The investigators' laboratory continues to study the biochemistry, regulation and genetics of the kidney (K or type 2) isozyme of 11 Beta-hydroxysteroid dehydrogenase (11-HSD) and its gene (HSD11K). This enzyme plays a crucial role in maintaining the specificity of the mineralocorticoid receptor. Mutations in the gene cause a Mendelian form of hypertension, the syndrome of apparent mineralocorticoid excess. In biochemical studies, they will express the wild type 11-HSD K isozyme in E. coli and compare its kinetic properties with those of the native enzyme in placenta and the recombinant enzyme expressed in cultured mammalian cells. They will then modify the enzyme to increase its solubility and activity, and use affinity chromatography to purify the enzyme to homogeneity in an active form. The investigators will characterize the relationship between the membrane spanning domains and enzymatic activity, and will characterize the nucleotide binding site of the enzyme. They will recreate mutations causing the syndrome of apparent mineralocorticoid excess in order to detect low levels of residual activity. The investigators will identify and characterize transcriptional regulatory elements in HSD11K. The investigators will use transient transfection of reporter constructs, electrophoretic mobility shift assays and DNAse I footprinting assays to study enhancer and silencer elements, and will identify possible locus control regions by looking for tissue-specific DNAse I hypersensitivity in chromatin. The investigators will confirm functioning of putative locus control regions by producing appropriate strains of transgenic mice. In genetic studies, they will identify additional mutations causing the syndrome of apparent mineralocorticoid excess and determine their functional effects in mammalian and/or bacterial expression systems. The investigators will determine the role of 11-HSD K in the development of essential hypertension, using both linkage and association studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK042169-09A1
Application #
2642077
Study Section
Special Emphasis Panel (ZRG2-MET (01))
Project Start
1990-08-15
Project End
2002-03-31
Budget Start
1998-04-22
Budget End
1999-03-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Mune, Tomoatsu; Morita, Hiroyuki; Takada, Nobuki et al. (2013) HSD11B2 CA-repeat and sodium balance. Hypertens Res 36:614-9
Mune, Tomoatsu; Suwa, Tetsuya; Morita, Hiroyuki et al. (2013) Longer HSD11B2 CA-repeat in impaired glucose tolerance and type 2 diabetes. Endocr J 60:671-8
Mune, Tomoatsu; Morita, Hiroyuki; Suzuki, Takashi et al. (2003) Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas. J Clin Endocrinol Metab 88:864-70
White, P C (2001) 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Am J Med Sci 322:308-15
White, P C; Agarwal, A K; Li, A et al. (2001) Possible association but no linkage of the HSD11B2 gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase to hypertension in Black people. Clin Endocrinol (Oxf) 55:249-52
Agarwal, A K (2001) Transcriptional influence of two poly purine-pyrimidine tracts located in the HSD11B2 (11beta-hydroxysteroid dehydrogenase type 2) gene. Endocr Res 27:1-9
White, P C; Agarwal, A K; Nunez, B S et al. (2000) Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase. Endocr Res 26:771-80
Agarwal, A K; White, P C (2000) Structure of the VPATPD gene encoding subunit D of the human vacuolar proton ATPase. Biochem Biophys Res Commun 279:543-7
Agarwal, A K; Giacchetti, G; Lavery, G et al. (2000) CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity. Hypertension 36:187-94
Agarwal, A K (2000) Expression of HSD11K (NAD+ dependent 11beta-hydroxysteroid dehydrogenase) promoter constructs in renal cell lines. Endocr Res 26:289-302

Showing the most recent 10 out of 49 publications